EVAX

Evaxion AS

3.29

-0.19-5.46%

After Hours: 3.350 +0.060 +1.82%16:00 02/20 EST

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE3.480/3.480

TODAY RANGE3.270-3.500

VOL12.15K

MARKET CAP27.44M

52 WEEK RANGE1.200-12.15

AVG VOL (3M)78.75K

% TURNOVER0.15%

TURNOVER--

P/E (TTM)-0.1949

% RANGE6.03%

EPS(TTM)-16.8820

P/E(FORWARD)-164.5000

P/B5.15

BVPS0.9857

DIVIDEND--

P/S1.380

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP22.65M

SHARES OUTSTANDING8.34M

NEXT EARNINGS--

FREE FLOAT6.88M

LOT SIZE1

EX-DATE01/14/2025

News

Press Releases

Financial Reports

Profile

TipRanks·3d ago
Evaxion Biotech initiated with a Buy at Maxim
TipRanks·01/13 14:16
Lake Street Sticks to Its Buy Rating for Evaxion Biotech (EVAX)
TipRanks·01/13 13:29
Evaxion Extends AI-Immunology Platform to Autoimmune Diseases and Sets 2026 Milestones
TipRanks·01/13 13:26
Evaxion Biotech expands AI-Immunology platform into autoimmune diseases
Reuters·01/13 13:00
Evaxion A/S Announces Expansion of AI-Immunology™ Platform Into Autoimmune Diseases and Outlines 2026 Milestones Including Biomarker Data, Clinical Efficacy Results, and Pipeline Advancements
TipRanks·01/07 13:43
Evaxion to Outline 2026 Milestones at Biotech Showcase in San Francisco
Reuters·01/07 13:00
Evaxion A/S to Present 2026 Milestones at Biotech Showcase Conference
Reuters·12/19/2025 18:56
BUZZ-U.S. STOCKS ON THE MOVE-Centrus Energy, Generac Holdings
Benzinga·12/19/2025 17:43
Evaxion Seeks New Partner For Gonorrhea Vaccine After Merck Opts Out
Reuters·12/19/2025 15:54
BUZZ-U.S. STOCKS ON THE MOVE-Centrus Energy, Oracle, Lamb Weston Holdings
Reuters·12/19/2025 14:09
BUZZ-U.S. STOCKS ON THE MOVE-Intuitive Machines, Palo Alto Networks, Redwire
TipRanks·12/19/2025 14:00
Analysts Have Conflicting Sentiments on These Healthcare Companies: Moderna (MRNA), Monopar Therapeutics Inc (MNPR) and Evaxion Biotech (EVAX)
Reuters·12/19/2025 13:13
BUZZ-Evaxion down after Merck opts out of gonorrhea vaccine licensing agreement
TipRanks·12/19/2025 12:44
Evaxion Retains Global Rights to Gonorrhea Vaccine EVX-B2 After MSD Declines Option
TipRanks·12/19/2025 12:11
Evaxion provides update on MSD collaboration, retains rights of EVX-B2

Same Industry

Name/Symbol

Change%

Price

Evaxion AS

EVAX

-5.46%

3.29

Regeneron Pharmaceuticals

REGN

-0.23%

779.67

GridAI Tech

GRDX

-5.15%

2.58

BIONTECH

BNTX

-0.25%

110.15

United Therapeutics Corp.

UTHR

-1.48%

473.42

Siga Technologie

SIGA

-0.30%

6.75

Vertex Pharmaceuticals Inc

VRTX

+1.63%

476.90

Moderna

MRNA

+0.34%

49.87

Charles Riv Labs Intl Inc

CRL

+2.85%

168.92

Medpace Holdings

MEDP

+1.64%

453.77

Talphera Inc

TLPH

-3.87%

0.7766

ICON PLC

ICLR

+1.31%

99.70

China Biologic

CBPO

119.99

Iqvia Hldgs Inc

IQV

-2.21%

165.62

MOLECULAR PARTNERS AG

MOLN

0.00%

5.00

PRA Health

PRAH

165.21

Arcturus Therape

ARCT

-3.76%

7.67

Gilead Sciences Inc

GILD

+0.19%

151.40

Incyte Corp

INCY

-0.40%

101.32

Aptevo Therapeutics Inc

APVO

-4.58%

6.66

Biospecifics

BSTC

+0.15%

88.53